Your browser doesn't support javascript.
loading
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial.
Sipos, O; Tovey, H; Quist, J; Haider, S; Nowinski, S; Gazinska, P; Kernaghan, S; Toms, C; Maguire, S; Orr, N; Linn, S C; Owen, J; Gillett, C; Pinder, S E; Bliss, J M; Tutt, A; Cheang, M C U; Grigoriadis, A.
Afiliación
  • Sipos O; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Tovey H; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Quist J; Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, UK.
  • Haider S; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Nowinski S; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, UK.
  • Gazinska P; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Kernaghan S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Toms C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Maguire S; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Orr N; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Owen J; King's Health Partners Cancer Biobank, London, UK.
  • Gillett C; King's Health Partners Cancer Biobank, London, UK.
  • Pinder SE; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, UK.
  • Bliss JM; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Tutt A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK; Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, Lon
  • Cheang MCU; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Grigoriadis A; Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, UK. Electronic address: anita.grigoriadis@kcl.ac.uk.
Ann Oncol ; 32(1): 58-65, 2021 01.
Article en En | MEDLINE | ID: mdl-33098992
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido